Literature DB >> 18535769

Laparoscopic splenectomy is a safe and effective procedure for patients with splenomegaly due to portal hypertension.

Takashi Hama1, Katsunari Takifuji, Kazuhisa Uchiyama, Masaji Tani, Manabu Kawai, Hiroki Yamaue.   

Abstract

BACKGROUND/
PURPOSE: This study was conducted retrospectively to examine whether laparoscopic splenectomy is an effective procedure for patients with splenomegaly due to portal hypertension in comparison to patients with a normal-sized spleen.
METHODS: From September 1994 to May 2005, we performed laparoscopic splenectomy in 50 patients at Wakayama Medical University Hospital, Japan. Of these, 17 patients with splenomegaly due to portal hypertension and 17 patients with idiopathic thrombocytopenic purpura (ITP) with normal-size spleen were enrolled in this study, in which we compared the surgical outcome between patients with splenomegaly due to portal hypertension and those without splenomegaly (ITP group).
RESULTS: The mean operative time (splenomegaly due to portal hypertension vs ITP; 171 vs 165 min; P = 0.7433) and estimated blood loss (248 vs 258 ml; P = 0.5396) were similar in the two groups. There were two patients with complications (11.8%) in the patients with splenomegaly due to portal hypertension and five patients with complications (29.4%) in those with ITP. All patients with splenomegaly due to portal hypertension showed appropriate increases in the platelet count following surgery. No perioperative mortality occurred.
CONCLUSIONS: We concluded that laparoscopic splenectomy was an effective procedure for splenomegaly due to portal hypertension, with findings being similar to those observed in patients with a normal-sized spleen (such as patients with ITP).

Entities:  

Mesh:

Year:  2008        PMID: 18535769     DOI: 10.1007/s00534-007-1232-7

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  8 in total

1.  Single-incision laparoscopic splenectomy using the "tug-exposure technique" in adults: results of ten initial cases.

Authors:  Takeyuki Misawa; Taro Sakamoto; Ryusuke Ito; Hiroaki Shiba; Takeshi Gocho; Shigeki Wakiyama; Yuichi Ishida; Katsuhiko Yanaga
Journal:  Surg Endosc       Date:  2011-04-22       Impact factor: 4.584

2.  Laparoscopic splenectomy: a surgeon's experience of 302 patients with analysis of postoperative complications.

Authors:  Xin Wang; Yongbin Li; Nicolas Crook; Bing Peng; Ting Niu
Journal:  Surg Endosc       Date:  2013-08-24       Impact factor: 4.584

Review 3.  Laparoscopic splenectomy for hypersplenism secondary to liver cirrhosis and portal hypertension.

Authors:  Xiao-Li Zhan; Yun Ji; Yue-Dong Wang
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

4.  Laparoscopic splenectomy is an effective and safe intervention for hypersplenism secondary to liver cirrhosis.

Authors:  Yun Qiang Cai; Jin Zhou; Xiao Dong Chen; Yi Chao Wang; Zhong Wu; Bing Peng
Journal:  Surg Endosc       Date:  2011-06-17       Impact factor: 4.584

Review 5.  Comparative treatment and literature review for laparoscopic splenectomy alone versus preoperative splenic artery embolization splenectomy.

Authors:  Zhong Wu; Jin Zhou; Prasoon Pankaj; Bing Peng
Journal:  Surg Endosc       Date:  2012-05-12       Impact factor: 4.584

6.  Efficacy and safety of laparoscopic splenectomy and esophagogastric devascularization for portal hypertension: A single-center experience.

Authors:  Shunzhen Zheng; Ping Sun; Xihan Liu; Guangbing Li; Wei Gong; Jun Liu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

7.  Left-sided portal hypertension: Successful management by laparoscopic splenectomy following splenic artery embolization.

Authors:  Damiano Patrono; Rosa Benvenga; Francesco Moro; Denis Rossato; Renato Romagnoli; Mauro Salizzoni
Journal:  Int J Surg Case Rep       Date:  2014-08-15

8.  Gastroesophageal Variceal Bleeding Successfully Controlled by Partial Splenic Embolization.

Authors:  Takayuki Kogure; Jun Inoue; Eiji Kakazu; Masashi Ninomiya; Tooru Shimosegawa
Journal:  Intern Med       Date:  2017-06-01       Impact factor: 1.271

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.